MINIRIN

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Israel, Japan, Lithuania, Mexico, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Tunisia, Turkey.

Active ingredients

The drug MINIRIN contains one active pharmaceutical ingredient (API):

1	Desmopressin UNII XB13HYU18U - DESMOPRESSIN ACETATE
	Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect.
	Read more about Desmopressin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01BA02	Desmopressin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues
Discover more medicines within H01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2129C, 8662X, 8663Y, 8711L, 8712M, 8975J, 9398P
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1973-MEE-0416, 29114-12-09
EE	Ravimiamet	1026492, 1064348, 1064360, 1064382, 1225550, 1225561, 1225572, 1225583, 1225594, 1225606, 1225617, 1225628, 1225639
FI	Lääkealan turvallisuus- ja kehittämiskeskus	022235, 022246, 022255, 022266, 022279, 022288, 022310, 022323, 456491
FR	Base de données publique des médicaments	62263894, 62822682, 64479727, 66842127, 67275313, 67576220, 69584479
HK	Department of Health Drug Office	30497, 30498, 32872, 37370, 37371, 54452, 54453, 66247
HR	Agencija za lijekove i medicinske proizvode	HR-H-052219211, HR-H-584681917, HR-H-794064519
IL	מִשְׂרַד הַבְּרִיאוּת	4410, 4411, 6063, 6064
JP	医薬品医療機器総合機構	2419001F1023, 2419001F2020, 2419001F3026, 2419001F4022, 2419001F5029
LT	Valstybinė vaistų kontrolės tarnyba	1001285, 1001286, 1001287, 1005614, 1005616, 1022380, 1022383, 1022385, 1022386
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	021M2009, 197M97, 520M96
NG	Registered Drug Product Database	B4-9870, B4-9871
NZ	Medicines and Medical Devices Safety Authority	12291, 12292, 12293, 2110, 2112, 2113
PL	Rejestru Produktów Leczniczych	100081060, 100081076, 100096014, 100096936, 100179390, 100179438, 100179450
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53989001, W53991001, W53991002, W53992001, W53992002, W53994001, W53994002
SG	Health Sciences Authority	03760P, 03761P, 04482P, 11615P, 11656P, 14260P, 14261P, 15615P
TN	Direction de la Pharmacie et du Médicament	2593021, 2593022, 2593023, 2593024, 5523011, 5523012, 5523013, 5523051
TR	İlaç ve Tıbbi Cihaz Kurumu	8697621010314, 8697621010321, 8697621010420, 8697621050211, 8697621050228, 8697621050235, 8697621050242, 8697621050372, 8697621050389, 8697621050457, 8697621050501, 8697621050518, 8697621540330, 8697621750357
ZA	Health Products Regulatory Authority	42/18.2/0345, 42/18.2/0346, 42/18.2/0347